Impact of fasting glucose on electrocardiographic left ventricular hypertrophy in an elderly general population

References

• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.
   PubMed Web of Science ®Google Scholar
• Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–8.
   PubMed Web of Science ®Google Scholar
• Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J. 1997;133:36–43.
   PubMed Web of Science ®Google Scholar
• Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ. Left ventricular hypertrophy by Sokolow–Lyon voltage criterion predicts mortality in overweight hypertensive subjects. J Hum Hypertens. 2009;23: 20–6.
   PubMed Web of Science ®Google Scholar
• Norman JE Jr, Levy D. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol. 1995;26:1022–9.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlof B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension. 2000;36:766–73.
   PubMed Web of Science ®Google Scholar
• Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:e50–103.
   PubMed Web of Science ®Google Scholar
• Lin TH, Chiu HC, Su HM, Voon WC, Liu HW, Lai WT, Sheu SH, et al. Association between fasting plasma glucose and left ventricular mass and left ventricular hypertrophy over 4 years in a healthy population aged 60 and older. J Am Geriatr Soc. 2007;55:717–24.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, et al. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens. 2008;26: 1602–11.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6.
   PubMed Web of Science ®Google Scholar
• Machado DB, Crow RS, Boland LL, Hannan PJ, Taylor HA, Folsom AR. Electrocardiographic findings and incident coronary heart disease among participants in the atherosclerosis risk in communities (ARIC) study. Am J Cardiol. 2006;97:1176–81.
   PubMed Web of Science ®Google Scholar
• Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave – the Copenhagen City Heart Study. Eur Heart J. 2002;23:315–24.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Sala C, Lonati L, Negri F, Rescaldani M, Re A, et al. Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study. Blood Press. 2013;22:138–43.
   PubMed Web of Science ®Google Scholar
• de Simone G, Okin PM, Gerdts E, Olsen MH, Wachtell K, Hille DA, et al. Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. Nutr Metab Cardiovasc Dis. 2009;19:634–40.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Jee JH, Kang M, Rhee EJ, Sung J, Lee MK. Metabolic syndrome and insulin resistance are associated with abnormal left ventricular diastolic function and structure independent of blood pressure and fasting plasma glucose level. Int J Cardiol. 2012;159:107–11.
   PubMed Web of Science ®Google Scholar
• Rerkpattanapipat P, D’Agostino RB Jr, Link KM, Shahar E, Lima JA, Bluemke DA, et al. Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis. Diabetes. 2009;58:946–53.
   PubMed Web of Science ®Google Scholar
• Somaratne JB, Whalley GA, Poppe KK, ter Baals MM, Wadams G, Pearl A, et al. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol. 2011;10:29.
   PubMed Web of Science ®Google Scholar
• Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgarde F. Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247:19–29.
   PubMed Web of Science ®Google Scholar
• Leosdottir M, Willenheimer R, Plehn J, Borgquist R, Gudmundsson P, Harris TB, et al. Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study. Am Heart J. 2010;159:414–20.e4.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage–duration products. J Am Coll Cardiol. 1995; 25:417–23.
   PubMed Web of Science ®Google Scholar
• Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161–86.
   PubMed Web of Science ®Google Scholar
• Diederichsen SZ, Gerke O, Olsen MH, Lambrechtsen J, Sand NP, Norgaard BL, et al. Coronary artery calcification and ECG pattern of left ventricular hypertrophy or strain identify different healthy individuals at risk. J Hypertens. 2013;31:595–600.
   PubMed Web of Science ®Google Scholar
• Halldin M, Fahlstadius P, de Faire U, Vikstrom M, Hellenius ML. The metabolic syndrome and left ventricular hypertrophy – the influence of gender and physical activity. Blood Press. 2012;21:153–60.
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75: 565–72.
   PubMed Web of Science ®Google Scholar
• Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391–8.
   PubMed Web of Science ®Google Scholar
• Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens. 1995;8:221–8.
   PubMed Web of Science ®Google Scholar
• Vernooij JW, Cramer MJ, Visseren FL, Korndewal MJ, Bots ML, Meijs MF, et al. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients. Am J Cardiol. 2012;110:227–33.
   PubMed Web of Science ®Google Scholar
• Velagaleti RS, Gona P, Chuang ML, Salton CJ, Fox CS, Blease SJ, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010;3:257–63.
   PubMed Web of Science ®Google Scholar
• Sciacqua A, Miceli S, Carullo G, Greco L, Succurro E, Arturi F, et al. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care. 2011;34:1406–11.
   PubMed Web of Science ®Google Scholar
• Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage–duration product. J Am Coll Cardiol. 1992;20:1180–6.
   PubMed Web of Science ®Google Scholar
• Dahlof B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension. 1998;32:989–97.
   PubMed Web of Science ®Google Scholar